Opportunistic Screening With Low-Dose Computed Tomography and Lung Cancer Mortality in China
Lijie Wang1,2,3, Yue Qi4, Ailing Liu5
1Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
Opportunistic low-dose computed tomography (LDCT) screening for lung cancer significantly reduced lung cancer deaths and all-cause mortality in adults. This screening method is a valuable addition to population-based screening programs.
Area of Science:
- Oncology
- Public Health
- Radiology
Background:
- Lung cancer screening guidelines exist, but participation rates, especially among high-risk individuals, remain low.
- Limited clinical data exist on the effectiveness of opportunistic low-dose computed tomography (LDCT) screening in reducing lung cancer mortality.
Purpose of the Study:
- To evaluate the association between opportunistic LDCT screening and improved prognosis in adults diagnosed with lung cancer in China.
Main Methods:
- A cohort study included 5234 lung cancer patients diagnosed between 2016-2021.
- Propensity score matching (PSM) was used to balance groups, followed by Cox regression analysis.
- Outcomes assessed were lung cancer-specific and all-cause mortality.
Main Results:
- After PSM, 2788 patients (1394 screened, 1394 not screened) were analyzed.
- Opportunistic LDCT screening was linked to a 49% lower risk of lung cancer death (HR, 0.51).
- A 46% lower risk of all-cause death was observed (HR, 0.54).
Conclusions:
- Opportunistic lung cancer screening with LDCT is associated with reduced lung cancer and all-cause mortality.
- These findings highlight opportunistic screening as a crucial supplement to population-based screening for improving lung cancer patient outcomes.
More Related Videos
08:14MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
